BlueStone Venture Partners
Venture capitalTucson · Seed–Series B · 4 people tracked
Investment thesis
BlueStone Venture Partners invests in life sciences and information technology companies that operate outside the traditional venture capital hubs of the United States, with a particular focus on the desert Southwest. The firm believes the region holds overlooked opportunities supported by strong universities, unique research centers, and significant infrastructure, yet underserved by venture capital. Leveraging its management expertise, established deal pipelines, and relationships with industry-leading advisors and co-investors, the firm aims to identify promising companies and create value for its investors.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website & public directories
What they invest in
from 5 of 8 portfolio companiesHealthtech ×4Biotech ×3Medical Devices ×3Advanced Manufacturing ×1AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Wellness & Fitness ×1
HQs:United States×3
Investments · 8 tracked
founders shown can be your intro pathAkadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products.
Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
James Militello(Executive Officer)Kalyan Handique(Executive Officer, Director)Douglas Neal(Director)John Younger(Executive Officer, Director)
BoardJeffrey S. Williams(Director)Paul D'Amato(Director)
BiotechScottsdale, US
Todd Levine(Executive Officer, Director)Christopher Gibbons(Director)Richard J. Morello(Executive Officer, Director)Peter Harris(Executive Officer, Director)Roy Freeman(Director)
BoardJack Seaver(Director)
Elucid offers PlaqueIQ, a non-invasive CT-based plaque analysis tool for cardiologists and radiologists to assess coronary and carotid plaque composition and enable patient-specific treatment pathways for cardiovascular disease prevention.
AI & Machine LearningHealthtechMedical Devices
PreludeDx develops DCISionRT, a biomarker-based diagnostic test for ductal carcinoma in situ (DCIS) breast cancer that helps physicians predict a patient's recurrence risk and whether they would benefit from radiation therapy after breast-conserving surgery.
BiotechHealthtechMedical Devices
Pyx Health provides a member engagement and activation solution for health plans, combining in-home fresh food delivery, human care teams, and a digital app to address non-medical drivers of health such as loneliness and food needs.
Digital HealthHealthtechWellness & FitnessTucson, US
Cynthia Jordan(Executive Officer, Director)
Portfolio news
latest coverage across their companiesAkadeum Life Sciences · finsmes.com · Jun 4, 2025
Frequently asked questions
- What stage does BlueStone Venture Partners invest at?
- BlueStone Venture Partners invests at the Seed, Series A, Series B stages.
- What is BlueStone Venture Partners's typical check size?
- BlueStone Venture Partners typically writes checks of $250K – $1M.
- What sectors does BlueStone Venture Partners focus on?
- BlueStone Venture Partners focuses on Biotech, Digital Health, Enterprise Software, Healthtech, Medical Devices, New Materials.
- Where is BlueStone Venture Partners located?
- BlueStone Venture Partners is headquartered in Tucson, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
New Science Ventures (NSV) is a venture capital firm based in Connecticut and London that backs companies applying novel scientific approaches in the life sciences and information technology sectors.
Osage University Partners (OUP) is a venture capital firm that invests in technology and life science startups, including companies spun out of university research, and typically co-invests alongside other strong VCs.
WRF Capital is the investment arm of the Washington Research Foundation, backing early-stage startups based in Washington state, particularly spinouts from local nonprofit research institutions.